Tuesday, November 17, 2026Published by SAM & FDPS · Our work → · Submit an op-ed →

Marijuana Testing Machines in California Fail to Detect Toxic Chemicals

Marijuana Testing Machines in California Fail to Detect Toxic Chemicals

Voters were promised that the legalization of recreational marijuana would result in the sale of safe and regulated marijuana products.…

By TDR StaffNovember 16, 20263 min read

Voters were promised that the legalization of recreational marijuana would result in the sale of safe and regulated marijuana products. However, a new report from the Los Angeles Times revealed that the machines used by many marijuana testing labs are flawed, thereby potentially exposing millions of consumers to deadly and carcinogenic chemicals.

Marijuana testing labs are suing PerkinElmer Health Sciences Inc. because its machine cannot reliably test marijuana for captan, chlorfenapyr, and chlordane, which have been linked to cancer and nervous system damage, according to the Los Angeles Times. The machine, known as QSight, was sold for as much as $470,000.

The Los Angeles Times, citing interviews with labs and lawsuit filings, noted that more than 40 labs nationwide have alleged that the machine did not work as promised. They also reported, “The extent of public exposure is unknown, but given the size of the California cannabis market and the labs involved, it is potentially very large, former lab operators say.”

WANT THE TRUTH ABOUT DRUGS?

Subscribe to The Drug Report to get the latest on science, policy, and much, much more.

Six marijuana labs requested that the California Attorney General open a criminal investigation into PerkinElmer. The report noted that state regulators were aware of issues with the QSight machine as early as 2018.

Free weekly briefing

Get stories like this every Friday

The week's drug policy news in one email, every claim sourced. Join tens of thousands of readers.

PerkinElmer announced in a 2018 press release, “For cannabis and hemp analysis, the high sensitivity of the QSight 400 Series supports laboratories in meeting state and federal regulations. PerkinElmer has developed a single LC/MS/MS method that meets pesticide and mycotoxin regulatory requirements—at levels well below state action limits, including California’s.”

In one lawsuit from a testing lab, a judge in Orange County ruled that PerkinElmer “fraudulently concealed material facts and misled” customers.

Jeff Gray, the CEO of SC Laboratories California, told the Los Angeles Times, “They were gaslighting us, telling you it’s your fault, it’s your fault,” pointing to how PerkinElmer would allege that employees were misusing the machine and not following protocols.

This is not what voters were promised when they voted for legalization in 2016. California’s voter guide explained:

  • The legalization policy was designed to “strictly control the cultivation, processing, manufacture, distribution, testing and sale of nonmedical marijuana through a system of state licensing, regulation, and enforcement.”
  • The policy would “require nonmedical marijuana to be comprehensively tested by independent testing services for the presence of contaminants, including mold and pesticides, before it can be sold by licensed businesses.”
  • “All marijuana and marijuana products shall be subject to quality assurance, inspection, and testing.”

These promises to voters came up short.

Similarly, a poll from Gallup found that one of the most highly rated arguments by supporters of legalization was that “government regulation of marijuana would make it safer for those who use it.” However, consumers in California––and likely other states––cannot be assured that the products in dispensaries are indeed safer than those sold in the illicit market.

Concern about harm to consumers is not hypothetical. In 2024, the Los Angeles Times tested marijuana products in California, which were ostensibly regulated, and found that more than half were positive for pesticides at levels exceeding either the state’s marijuana regulations or federal tobacco regulations.

Notably, this issue is not unique to California. In Colorado, a state audit found that 75% of marijuana products processed for sale between 2023 and 2023 were not tested for contaminants. The audit concluded, “As a result, there is an increased risk that marijuana products sold in Colorado may have contaminants or that the potency listed on the labels is inaccurate.”

Together, marijuana cultivators are using prohibited chemicals, while testing labs are using flawed machines that are failing to detect them.

Get The Drug Report every Friday

One free email every Friday: the week's drug policy news, sourced and explained. Read by tens of thousands of people who write, enforce and cover the policy. Unsubscribe anytime.

Scroll to Top